期刊文献+

原发性胆汁性肝硬化AMA-M_2阴性患者的临床及病理特点 被引量:11

Clinical and pathological features of primary biliary cirrhotic patients with negative anti-mitochondria antibody M_2 subtype
下载PDF
导出
摘要 目的:探讨原发性胆汁性肝硬化(primary biliary cirrhosis,PBC)中AMA-M2阴性患者的临床及病理特点.方法:2000-2007年昆明医学院第二附属医院PBC患者56例.分析AMA-M2阴性PBC患者临床资料及病理资料,并与AMA-M2阳性患者临床资料进行对比.结果:AMA-M2抗体阳性与阴性患者间一般资料及血清指标均无显著性差异(均P>0.05).22例AMA-M2阴性PBC患者胆管改变明显,以小胆管最具特征性,其表现与所处的分期有关,胆管周围见炎性细胞浸润,以淋巴细胞为主;汇管区细胞浸润现象明显,以淋巴细胞最为重要,甚至形成淋巴滤泡;肝细胞改变相对较轻,缺乏特异性;同一份标本可见不同时期的改变,各期改变可相互混杂.结论:病理组织学是确诊AMA-M2阴性患者的重要检查,同时是分期的重要标准. AIM: To explore the clinical and pathological features of primary biliary cirrhotic (PBC) patients with negative antiitochondria antibody M2 subtype (AMA-M2). METHODS: Fifty six PBC cases from the second affiliated hospital of Kunming Medical College between AD 2000 and 2007 were selected. The clinical data (general status, laboratory findings) and pathologic data were reviewed in 22 cases of negative AMA-M2 antibody. And the clinical data of the negative AMA-M2 anti-body cases were compared with the positive ones. RESULTS: The general status and laboratory findings (biochemical data, immune function) of AMA-M2 antibody negative were compared with the positive ones, with no significant difference observed (all P 〉 0.05). Remarkable changes in bileducts, especially in small bile ducts were observed in 22 negative AMA-M2 antibody cases. Those changes were related to staging. Inflammatory cells, mainly lymphocytes were seen around the bile duct. Remarkable infiltrated inflammatory cells, mainly lymphocytes, even lymphoid follicles were observed in the portal area. Liver cells changed mildly and were non-specific. The changes of different stages existed and intermixed in one sample. CONCLUSION: Liver biopsy is useful to confirm to diagnosis of PBC with negative M2 antibody and an important criteria for staging determination.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第16期1676-1679,共4页 World Chinese Journal of Digestology
关键词 原发性胆汁性肝硬化 抗线粒体抗体 病理学 Primary biliary cirrhosis Anti-mitochon-dria antibody Pathology
  • 相关文献

参考文献16

  • 1Heathcote EJ.Management of primary biliary cirrhosis.The American Association for the Study of Liver Diseases practice guidelines.Hepatology 2000; 31:1005-1013
  • 2Sakauchi F,Mori M,Zeniya M,Toda G.A crosssectional study of primary biliary cirrhosis in Japan:utilization of clinical data when patients applied to receive public financial aid.J Epidemiol 2005; 15:24-28
  • 3Pares A,Rodes J.Natural history of primary biliary cirrhosis.Clin Liver Dis 2003; 7:779-794
  • 4姚光弼.重视原发性胆汁性肝硬化的临床研究[J].中华肝脏病杂志,2002,10(5):325-326. 被引量:33
  • 5Invernizzi P,Battezzati PM,Crosignani A,Perego F,Poli F,Morabito A,De Arias AE,Scalamogna M,Zuin M,Podda M.Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis.J Hepatol 2003; 38:401-406
  • 6Padgett KA,Selmi C,Kenny TP,Leung PS,Balkwill DL,Ansari AA,Coppel RL,Gershwin ME.Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans,implications for primary biliary cirrhosis.J Autoimmun 2005; 24:209-219
  • 7Howel D,Fischbacher CM,Bhopal RS,Gray J,Metcalf JV,James OF.An exploratory populationbased case-control study of primary biliary cirrhosis.Hepatology 2000; 31:1055-1060
  • 8Neuberger J,Thomson R.PBC and AMA--what is the connection? Hepatology 1999; 29:271-276
  • 9姜小华,仲人前,方晓云,安峰,胡寅,汪修平,孔宪涛.抗线粒体抗体M2抗原诱导小鼠原发性胆汁性肝硬化模型的建立[J].中华肝脏病杂志,2006,14(3):202-204. 被引量:13
  • 10Muratori P,Muratori L,Ferrari R,Cassani F,Bianchi G,Lenzi M,Rodrigo L,Linares A,Fuentes D,Bianchi FB.Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.Am J Gastroenterol 2003; 98:431-437

二级参考文献7

共引文献66

同被引文献84

引证文献11

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部